Journal of International Psychiatry

Objective: To observe the effect of EEG biofeedback therapy on patients with depression and sleep disorders.Method: A total of 84 patients with depression and sleep disorders who were treated in hospital were selected and enrolled from January 2021 to November 2022 by random number table method. 42 patients in the conventional group were given conventional Western medicine treatment, while 42 patients in the exploration group were given EEG biofeedback therapy on the basis of conventional Western medicine treatment. Before and after treatment, sleep quality of patients in two groups was detected: sleep efficiency, proportion of slow-wave sleep (III+IV); Eeg indicators were detected: incubation period of mismatched negative wave (MMN). Rosenberg Self-esteem Scale (SES) and Hamilton Depression Scale were evaluated, and clinical efficacy was compared between the conventional group and the inquiry group.Results: The proportion of phase III+IV and sleep efficiency in the study group were significantly higher than those in the conventional group (P < 0.05). The incubation period of MMN in the exploration group was lower than that in the conventional group (P < 0.05). HAMD score in the inquiry group was lower than that in the conventional group, SES score and total effective rate were higher than that in the conventional group (P < 0.05).Conclusion:Eeg biofeedback therapy in the treatment of patients with depression and sleep disorders can improve their sleep quality, EEG indicators, self-esteem and clinical efficacy

Key words: EEG biofeedback therapy; Depression with sleep disorders; Electroencephalogram; Self-esteem level